If you made any changes in Pure these will be visible here soon.

Fingerprint The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.

  • 22 Similar Profiles

Network Dive into details by clicking on the dots.

Research Output

  • 22 Journal article
  • 15 Conference abstract in journal
  • 2 Poster
  • 1 Conference article in Journal

Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies

Vergote, I. B., Lund, B., Peen, U., Umajuridze, Z., Mau-Sorensen, M., Kranich, A., Van Nieuwenhuysen, E., Haslund, C., Nottrup, T., Han, S. N., Concin, N., Unger, T. J., Chai, Y., Au, N., Rashal, T., Joshi, A., Crochiere, M., Landesman, Y., Shah, J., Shacham, S. & 2 others, Kauffman, M. & Mirza, M. R., Feb 2020, In : Gynecologic Oncology. 156, 2, p. 308-314 7 p.

Research output: Contribution to journalJournal articleResearchpeer-review

4 Citations (Scopus)

Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer: A randomized controlled chemotherapy-free study-NSGO-AVANOVA2/ENGOT-OV24.

Mirza, M. R., Avall-Lundqvist, E., Birrer, M. J., Christensen, R. D., Nyvang, G-B., Malander, S., Anttila, M., Werner, T. L., Lund, B., Lindahl, G., Hietanen, S., Peen, U., Dimoula, M., Roed, H., Knudsen, A. O., Boufercha, L., Staff, S., Vistisen, A. K., Bjorge, L. & Maenpaa, J. U., 20 May 2019, In : Journal of Clinical Oncology. 37, 15, Suppl., 5505.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

González-Martín, A., Pothuri, B., Vergote, I., DePont Christensen, R., Graybill, W., Mirza, M. R., McCormick, C., Lorusso, D., Hoskins, P., Freyer, G., Baumann, K., Jardon, K., Redondo, A., Moore, R. G., Vulsteke, C., O'Cearbhaill, R. E., Lund, B., Backes, F., Barretina-Ginesta, P., Haggerty, A. F. & 11 others, Rubio-Pérez, M. J., Shahin, M. S., Mangili, G., Bradley, W. H., Bruchim, I., Sun, K., Malinowska, I. A., Li, Y., Gupta, D., Monk, B. J. & PRIMA/ENGOT-OV26/GOG-3012 Investigators, 19 Dec 2019, In : The New England Journal of Medicine. 381, 25, p. 2391-2402 12 p.

Research output: Contribution to journalJournal articleResearchpeer-review

  • 119 Citations (Scopus)

    Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

    Del Campo, J. M., Matulonis, U. A., Malander, S., Provencher, D., Mahner, S., Follana, P., Waters, J., Berek, J. S., Woie, K., Oza, A. M., Canzler, U., Gil-Martin, M., Lesoin, A., Monk, B. J., Lund, B., Gilbert, L., Wenham, R. M., Benigno, B., Arora, S., Hazard, S. J. & 1 others, Mirza, M. R., 10 Nov 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 32, p. 2968-2973 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

    Open Access
    File
  • 12 Citations (Scopus)
    7 Downloads (Pure)

    Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

    Mirza, M. R., Åvall Lundqvist, E., Birrer, M. J., dePont Christensen, R., Nyvang, G-B., Malander, S., Anttila, M., Werner, T. L., Lund, B., Lindahl, G., Hietanen, S., Peen, U., Dimoula, M., Roed, H., Ør Knudsen, A., Staff, S., Krog Vistisen, A., Bjørge, L., Mäenpää, J. U., AVANOVA investigators & 1 others, Lund, B., Oct 2019, In : The Lancet. Oncology. 20, 10, p. 1409-1419 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  • 23 Citations (Scopus)